Concentrated sweet pomegranate extract by breastfeeding mothers, in jaundice

Phase 3

• Conditions: eonatal jaundice.; Neonatal jaundice, unspecified; P59.9

• Registration Number: IRCT20200105046009N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

Mothers of term infants (GA over 37 weeks)
serum total bilirubin level of more than 15 mgr / dl
over 48 hours of age
breastfeed
weighing more than 2,500 grams
under phototherapy for the treatment of hyperbilirubinemia in the neonatal ward of Babol Shafizadeh Children's Hospital

Exclusion Criteria

Hemolytic disease (ABO, Rh incompatibility), G6PD deficiency in neonate
Blood exchange in neonate
Direct hyperbilirubinemia in neonate
hyperbilirubinemia in neonate in the first 24 hours of life
Systemic diseases such as liver, heart disease and hypothyroidism in neonate
History of use of phenobarbital or other drugs or remedies in neonate
sepsis in neonate
respiratory distress in neonate
Sensitivity to eating pomegranate juice in the mother

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eonates bilirubin levels in blood. Timepoint: daily after hospitalization. Method of measurement: Bilirubin is checked by Diazo (photometeric) method with Darman Faraz Kave kits made in Iran.

Secondary Outcome Measures

Name	Time	Method
The duration of phototherapy. Timepoint: The days of phototherapy for neonate. Method of measurement: The duration (days) of phototherapy.;The duration of hospitalization. Timepoint: the duration of hospitalization of neonates. Method of measurement: The duration (days) of phototherapy.;The need for blood transfusions. Timepoint: during hospitalization. Method of measurement: Is blood transfusions performed or not?.